Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16098252)

  • 1. Tumor response to neoadjuvant chemoradiation therapy for rectal adenocarcinoma is mediated by p53-dependent and caspase 8-dependent apoptotic pathways.
    Kelley ST; Coppola D; Yeatman T; Marcet J
    Clin Colorectal Cancer; 2005 Jul; 5(2):114-8. PubMed ID: 16098252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 protein overexpression and response to induction chemoradiation therapy in patients with locally advanced rectal adenocarcinoma.
    Luna-Perez P; Arriola EL; Cuadra Y; Alvarado I; Quintero A
    Ann Surg Oncol; 1998; 5(3):203-8. PubMed ID: 9607618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of molecular markers as a method to predict the response to neoadjuvant therapy for advanced stage rectal adenocarcinoma.
    Edden Y; Wexner SD; Berho M
    Colorectal Dis; 2012 May; 14(5):555-61. PubMed ID: 21689364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancer.
    Spitz FR; Giacco GG; Hess K; Larry L; Rich TA; Janjan N; Cleary KR; Skibber JM
    Clin Cancer Res; 1997 Oct; 3(10):1685-90. PubMed ID: 9815551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased endocrine cells in treated rectal adenocarcinomas: a possible reflection of endocrine differentiation in tumor cells induced by chemotherapy and radiotherapy.
    Shia J; Tickoo SK; Guillem JG; Qin J; Nissan A; Hoos A; Stojadinovic A; Ruo L; Wong WD; Paty PB; Weiser MR; Minsky BD; Klimstra DS
    Am J Surg Pathol; 2002 Jul; 26(7):863-72. PubMed ID: 12131153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biopsy specimens obtained 7 days after starting chemoradiotherapy (CRT) provide reliable predictors of response to CRT for rectal cancer.
    Suzuki T; Sadahiro S; Tanaka A; Okada K; Kamata H; Kamijo A; Murayama C; Akiba T; Kawada S
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1232-8. PubMed ID: 23158058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic Complete Response in Rectal Cancer: Can We Detect It? Lessons Learned From a Proposed Randomized Trial of Watch-and-Wait Treatment of Rectal Cancer.
    Nahas SC; Rizkallah Nahas CS; Sparapan Marques CF; Ribeiro U; Cotti GC; Imperiale AR; Capareli FC; Chih Chen AT; Hoff PM; Cecconello I
    Dis Colon Rectum; 2016 Apr; 59(4):255-63. PubMed ID: 26953983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant therapy for adenocarcinoma of the rectum: tumor response and acute toxicity.
    Read TE; McNevin MS; Gross EK; Whiteford HM; Lewis JL; Ratkin G; Picus J; Birnbaum EH; Fleshman JW; Kodner IJ; Myerson RJ
    Dis Colon Rectum; 2001 Apr; 44(4):513-22. PubMed ID: 11330578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of Ki67 and p53 in locally advanced rectal cancer: correlation with thymidylate synthase and histopathological tumor regression after neoadjuvant 5-FU-based chemoradiotherapy.
    Jakob C; Liersch T; Meyer W; Becker H; Baretton GB; Aust DE
    World J Gastroenterol; 2008 Feb; 14(7):1060-6. PubMed ID: 18286688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment Tumor Thickness as a Predictor of Pathologic Complete Response to Neoadjuvant Chemoradiation Therapy for Stage II/III Rectal Adenocarcinoma.
    Xu B; Chen Y; Guo Y; Zhou D; Yue Z; Duan Q; Yang Y; Guan G; Chi P; Lin C
    Am J Clin Oncol; 2018 Jun; 41(6):601-606. PubMed ID: 27672742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nodal Disease in Rectal Cancer Patients With Complete Tumor Response After Neoadjuvant Chemoradiation: Danger Below Calm Waters.
    Baucom RB; Maguire LH; Kavalukas SL; Geiger TM; Ford MM; Muldoon RL; Hopkins MB; Hawkins AT
    Dis Colon Rectum; 2017 Dec; 60(12):1260-1266. PubMed ID: 29112561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic markers predictive of response to induction chemoradiotherapy for locally advanced rectal cancers.
    Kudrimoti M; Lee EY; Kang Y; Ahmed M; Mohiuddin M
    J Ky Med Assoc; 2007 Jan; 105(1):18-22. PubMed ID: 17310874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survivin, p53, and Ki-67 as predictors of histopathologic response in locally advanced rectal cancer treated with preoperative chemoradiotherapy.
    Terzi C; Canda AE; Sagol O; Atila K; Sonmez D; Fuzun M; Gorken IB; Oztop I; Obuz F
    Int J Colorectal Dis; 2008 Jan; 23(1):37-45. PubMed ID: 17805549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imunoexpression of Ki-67 and p53 in rectal cancer tissue after treatment with neoadjuvant chemoradiation.
    Andrade NR; Oshima CT; Gomes TS; Neto RA; Forones NM
    J Gastrointest Cancer; 2011 Mar; 42(1):34-9. PubMed ID: 21049307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.
    Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A
    Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy, concomitant protracted-venous-infusion 5-fluorouracil, and surgery for ultrasound-staged T3 or T4 rectal cancer.
    Mehta VK; Poen J; Ford J; Edelstein PS; Vierra M; Bastidas AJ; Young H; Fisher G
    Dis Colon Rectum; 2001 Jan; 44(1):52-8. PubMed ID: 11805563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can a biomarker-based scoring system predict pathologic complete response after preoperative chemoradiotherapy for rectal cancer?
    Hur H; Kim NK; Min BS; Baik SH; Lee KY; Koom WS; Ahn JB; Kim H
    Dis Colon Rectum; 2014 May; 57(5):592-601. PubMed ID: 24819099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Nomogram to Predict Lymph Node Positivity Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.
    Newton AD; Li J; Jeganathan AN; Mahmoud NN; Epstein AJ; Paulson EC
    Dis Colon Rectum; 2016 Aug; 59(8):710-7. PubMed ID: 27384088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status.
    Read TE; Andujar JE; Caushaj PF; Johnston DR; Dietz DW; Myerson RJ; Fleshman JW; Birnbaum EH; Mutch MG; Kodner IJ
    Dis Colon Rectum; 2004 Jun; 47(6):825-31. PubMed ID: 15108025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome standards for an organ preservation strategy in stage II and III rectal adenocarcinoma after neoadjuvant chemoradiation.
    Wolthuis AM; Penninckx F; Haustermans K; Ectors N; Van Cutsem E; D'Hoore A
    Ann Surg Oncol; 2011 Mar; 18(3):684-90. PubMed ID: 20842458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.